Prosecution Insights
Last updated: April 19, 2026

Sanofi-Aventis U S LLC

2 pending office actions

Portfolio Summary

2
Total Pending OAs
0
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17517567 USE OF ISATUXIMAB FOR THE TREATMENT OF MULTIPLE MYELOMA SULLIVAN, DENNIS JOHN 1642 Non-Final OA Nov 02, 2021
17112862 USE OF ISATUXIMAB FOR THE TREATMENT OF RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA SKOKO III, JOHN JOSEPH 1643 Non-Final OA Dec 04, 2020

Managing Sanofi-Aventis U S LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month